SCHEMBL4929407

SCHEMBL4929407

CCOc1nc2ccccc2n1C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.47
PSMD14 O00487 1/20 0.47
ASAH1 Q13510 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
TSHR P16473 2/20 0.44
ALDH1A1 P00352 4/20 0.44
MAPK1 P28482 2/20 0.44
MAPT P10636 1/20 0.44
PKM P14618 1/20 0.44
POLB P06746 1/20 0.44
CASP1 P29466 1/20 0.43
CASP7 P55210 1/20 0.43
KMT2A Q03164 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
KDM4E B2RXH2 2/20 0.43
HSD17B10 Q99714 2/20 0.43
CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29178107 0.87 GAA (0.59) GAAPSMD14L3MBTL1TSHRALDH1A1
SCHEMBL29795450 0.80 ASAH1 (0.69) GAAASAH1L3MBTL1TSHRALDH1A1
SCHEMBL28794854 0.80 ASAH1 (0.69) GAAASAH1L3MBTL1TSHRALDH1A1
SCHEMBL28794826 0.79 ALDH1A1 (0.65) GAAASAH1L3MBTL1TSHRALDH1A1
SCHEMBL29795738 0.79 ALDH1A1 (0.65) GAAASAH1L3MBTL1TSHRALDH1A1
SCHEMBL13543523 0.76 RAB9A (0.54) L3MBTL1MAPTPKMKMT2ASMN1; SMN2
SCHEMBL29145183 0.75 CNR2 (0.47) GAAALDH1A1MAPK1POLBCASP1
SCHEMBL27945131 0.74 KMT2A (0.68) GAAASAH1TSHRALDH1A1MAPK1
SCHEMBL11826645 0.73 TSHR (0.56) GAAPSMD14L3MBTL1TSHRALDH1A1
SCHEMBL2461861 0.73 RAB9A (0.53) ASAH1L3MBTL1TSHRALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080214637-A1 Process for the Synthesis of Tetrazoles LEK PHARMACEUTICALS D.D. (SI) 2008-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214637-A1 Process for the Synthesis of Tetrazoles HAO2, TALDO1, TST GAA 338/4885PSMD14 2724/4885ASAH1 2536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.